ROSENBLUM MARK J (Exec VP Finance, Interim CFO) received a stock award from DECOY THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/5/2022ACC: 0001615219-22-000067
Officer· Exec VP Finance, Interim CFO
Since Sep 2019
+10K
Net shares
Net buyer
$1.9K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10K
Price / share
$0.19
Trade value
$1.86K
% of position
9.1%
5/3/2022
110.32K→120.32K
Total
Net shares
+10K
Net value
$1.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/3/2022 | A · Award | +10K | $0.19 | $1.86K | 9.1% | 110.32K | 120.32K |
| Total | +10K | $1.86K | ||||||
Derivative Transactions0
No derivative transactions reported